Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 12
Submit an article Journal homepage
311
Views
6
CrossRef citations to date
0
Altmetric
Letters to the Editor

Acute promyelocytic leukemia (APL) with an IRF2BP2-RARA fusion transcript: an aggressive APL variant

Ahmad S. Alotaibia Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Mustafa Abdulrazzaqb Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Keyur P. Patelb Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Farhad Ravandia Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Sergej Konoplevb Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Carlos Bueso-Ramosb Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
C. Cameron Yinb Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Tariq Muzzafarb Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Guilin Tangb Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0002-9482-4806View further author information
ORCID Icon,
Andrew Futrealc Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Nitin Jaina Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Marina Y. Konoplevaa Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
&
Naveen Pemmarajua Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
View further author information
 show all
Pages 3018-3020 | Received 07 May 2020, Accepted 30 Jun 2020, Published online: 11 Jul 2020
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure statement

NP: Consulting/honorarium: Celgene; Stemline; Incyte; Novartis; MustangBio; Roche Diagnostics, LFB, Pacylex.

Research funding/clinical trials support: Stemline; Novartis; Abbvie; Samus; Cellectis; Plexxikon; Daiichi-Sankyo; Affymetrix, SagerStrong Foundation.

NJ: Research funding has been provided to the institution from Pharmacyclics, AbbVie, Genentech, AstraZeneca, BMS, Pfizer, ADC Therapeutics, Incyte, Servier, Cellectis, Verastem, Adaptive Biotechnologies, and Precision Biosciences for clinical studies in which Nitin Jain is a principal investigator. Nitin Jain has participated in advisory board meeting and received honoraria from Pharmacyclics, Janssen, AbbVie, Genentech, AstraZeneca, Verastem, Adaptive Biotechnologies, Servier, and Precision Biosciences.

Additional information

Funding

This research is supported in part by the M. D. Anderson Cancer Center Support Grant P30 CA016672 and the SagerStrong Foundation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.